GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
| 
                                                                Synonyms: A-500359 B | antibiotic 446-S3-1
                                 Compound class: 
                                                            Natural product
                                 
                                    
                                        Comment: Capuramycin is a nucleoside antibacterial compound, with activity against Gram-positive bacteria and mycobacteria, and that was initially isolated from the culture filtrate of Streptomyces griseus 446-S3 [5]. It inhibits phospho-N-acetylmuramoyl-pentapeptide-transferase (MraY, translocase I) [3], an essential enzyme in bacterial peptidoglycan biosynthesis.
                                    
                                 | 
 | |||||||||||||||||||||||||||||||||||
| No information available. | 
| Mechanism Of Action and Pharmacodynamic Effects  | 
| Capuramycin is one of a number of nucleoside antibacterial natural products that interfere with bacterial cell wall synthesis by inhibiting phospho-N-acetylmuramoyl-pentapeptide-transferase (MraY). This essential enzyme catalyzes the first reaction in the biosynthesis of the cell wall peptidoglycan, transfering the peptidoglycan precursor phospho-MurNAc-pentapeptide to the membrane lipid carrier undecaprenyl phosphate, yielding undecaprenyl-pyrophosphoryl-MurNAc-pentapeptide (lipid I) [1-2,4]. |